E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: Secondary analysis of data from the ASCEND trial Dr Maciej L. Goniewicz

Tobacco Induced Diseases

Volumn 13, Issue 1, 2015, Pages

  O'Brien, Brigid ^a   Knight West, Oliver ^a   Walker, Natalie ^a   Parag, Varsha ^a   Bullen, Christopher ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Electronic cigarette e cigarette; Harm reduction; Mental illness; Nicotine; Smoking cessation; Tobacco

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ELECTRONIC CIGARETTE; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; NICOTINE; NICOTINE PATCH;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE;

EID: 84925442772     PISSN: None     EISSN: 16179625     Source Type: Journal    
DOI: 10.1186/s12971-015-0030-2     Document Type: Article

References (36)

1. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212-7.
2. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction. 2010;105(7):1176-89.
3. Campion J, Checinski K, Nurse J, McNeill A. Smoking by people with mental illness and benefits of smoke-free mental health services. Adv Psychiatr Treat. 2008;14:217-28.
4. Smith PH, Homish GG, Giovino GA, Kozlowski LT. Cigarette smoking and mental illness: a study of nicotine withdrawal. Am J Public Health. 2014;104(2):e127-33. doi:10.2105/ajph.2013.301502.
5. Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23(e2):e147-53. doi:10.1136/tobaccocontrol-2013-051466.
6. Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C, Kakouris G, et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res. 2014;48(1):102-10.
7. Centers for Disease Control and Prevention. Vital signs: Current cigarette smoking among adults aged aged ≥ 18 Years - United States, 2009-2011. MMWR Morb Mortal Wkly Rep. 2013;62(5):81-7.
8. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357-76.
9. McManus S, Meltzer H, Brugha T, Bebbington P, Jenkins R. Adult Psychiatric Morbidity Survey 2007. Results of a household survey. The NHS Health & Social Care Information Centre, Social Care Statistics; 2009. http://www.hscic.gov.uk/catalogue/PUB02931/adul-psyc-morb-res-hou-sur-eng-2007-rep.pdf
10. McCreadie R, Kelly C. Patients with schizophrenia who smoke. Private disaster, public resource. Br J Psychiatry. 2000;176:109.
11. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction. 2009;104(5):719-33.
12. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;2:CD007253. doi:10.1002/14651858.CD007253.pub3.
13. Pachas G, Cather C, Pratt S, Hoeppner B, Nino J, Carlini S, et al. Varenicline for smoking cessation in schizophrenia: safety and effectiveness in a 12-week, open-label trial. J Dual Diagn. 2012;8(2):1178-125.
14. Rüther T, Bobes J, De Hert M, Svensson TH, Mann K, Batra A, et al. EPA Guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry. 2014;29(2):65-82. http://dx.doi.org/10.1016/j.eurpsy.2013.11.002.
15. van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013;8:CD006102. doi:10.1002/14651858.CD006102.pub2.
16. Kishi T, Iwata N. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014. doi:10.1007/s00406-014-0551-3
17. Parker C, McNeill A, Ratschen E. Tailored tobacco dependence support for mental health patients: a model for inpatient and community services. Addiction. 2012;107 Suppl 2:18-25.
18. Royal College of Physicians. Smoking and Mental Health. London: RCP; 2013.
19. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014;311(2):172-82. doi:10.1001/jama.2013.284985.
20. Caponnetto P, Campagna D, Cibella F, Morjaria J, Caruso M, Russo C, et al. Efficiency and Safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317. doi:10.1371/journal.pone.0066317.
21. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629-37. http://dx.doi.org/10.1016/S0140-6736(13)61842-5.
22. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: an eight-week flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health. 2014;11(11):11220-48. doi:10.3390/ijerph111111220.23.
23. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10(2):446-61. http://dx.doi.org/10.3390/ijerph10020446.
24. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep. 2011;5:585.
25. Caponnetto P, Polosa R, Auditore R, Russo C, Campagna D. Smoking cessation with e-cigarettes in smokers with a documented history of depression and recurring relapses. Int J Clin Med. 2011;2:281-4.
26. Schneiderhan M. A case report of patient-initiated e-cigarette use and resulting 5-months smoking cessation. J Pharm Pract. 2012;25(2):297.
27. Cummins SE, Zhu S-H, Tedeschi GJ, Gamst AC, Myers MG. Use of e-cigarettes by individuals with mental health conditions. Tob Control. 2014;23 suppl 3:iii48-53. doi:10.1136/tobaccocontrol-2013-051511.
28. Prochaska JJ, Grana RA. E-Cigarette Use among Smokers with Serious Mental Illness. PLoS One. 2014;9(11):e113013.
29. Bullen C, Williman J, Howe C, Laugesen M, McRobbie H, Parag V, et al. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health. 2013;13:210. doi:10.1186/471-2458-13-210.
30. WHO Collaborating Centre for Drug Statistics Methodology. ATC structure and principles. 2011. [cited 2013 29/11/13]; Available from: http://www.webcitation.org/6LTkY7A7C.
31. Heatherton T, Kozlowski L, Frecker R, Fagerstrom K. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119-27.
32. Glover ED, Nilsson F, Westin A, Glover PN, Laflin MT, Persson B. Developmental history of the Glover-Nilsson smoking behavioral questionnaire. Am J Health Behav. 2005;29(5):443-55. doi:10.5555/ajhb.2005.29.5.443.
33. DiFranza JR, Wellman RJ, Ursprung WW, Sabiston C. The autonomy over smoking scale. Psychol Addict Behav. 2009;23(4):656-65. doi:10.1037/a0017439.
34. Hajek P. Electronic cigarettes for smoking cessation. Lancet. 2013. http://dx.doi.org/10.1016/S0140-6736(13)61534-2.
35. NICE. National Institute for Health and Clinical Excellence (NICE). Tobacco: harm-reduction approaches to smoking. PH45. 2013 01-Dec-2014; Available from: https://www.nice.org.uk/guidance/ph45.
36. Wilson N, Weerasekera D, Collings S, Edwards R, Deen FS. Poorer mental health in many New Zealand smokers: national survey data from the ITC Project. N Z Med J. 2010;123(1326):129-32.